We investigated the effects of by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors, cerivastatin and iluvastatin, on the induction of nitric oxide (NO) production in vascular smooth muscle cells ( VSMC) stimulated by interleukin-lß (1L-1) or in combination with interferon-γ (IHN). II.-1 activated VSMC to synthesize and release NO, which was significantly potentiated by IFN. NO production induccd by II.-1 or Π,-1/ll'N was dosedependently enhanced by both HMG-CoA reductase inhibitors. Incubating VSMC with IL-l/IFN stimulated inducible NO synthase (iNOS) mRNA expression. Both ITMG-CoA reductase inhibitors significantly upreguMted IT.-FIFN-stimulated iNOS mRNA expression, and enhanced iNOS gene transcription as shown by nuclear run-on assays. Both IIMG-CoA reductase inhibitors slightly modulated IL-i/IFN-indueed NF-kB activation, which was not associated with their effect on NO production. Cytokines induce the de novo synthesis of tetrahydrobiopterin (BII4) in VSMC. This event is essential for the induction of NO synthesis, which requires transcriptional induction of the genes that encode not only iNOS but also guanosine triphosphate cyclohydrolase I i GTPCI1), the first and rate-limiting enzyme in de novo Blk synthesis. The synthesis of BII4 and GFPCII mRNA induced by II.-1/Π'Ν were enhanced by both HMG-CoA reductase inhibitors. Hxogenous mevalonate significantly prevented and geranylgeranylpyrophosphate reversed the stimulatory effect of HMG-CoA reductase inhibitors. Thus, the effect of HMG-CoA reductase inhibitors 011 NO production is due at least partly through blocking the biosynthesis of mevalonate, which prevents isoprenoid biosynthesis. Our data demonstrated that HMG-CoA reductase inhibitors enhance immunostimulants-induced NO production by increasing iNOS gene expression at the transcriptional level via an NF-tcB-independent pathway. In addition to augmenting iNOS expression, IIMG-CoA reductase inhibitors potentiate GTPCIT gene expression and BH4 synthesis, thereby prevents a relative shortage of BII4 which may shift in the balance between NOS-catalyzed generation of protective NO and deleterious reactive oxygen species.
Introduction
l arge clinical trials have shown that the inhibition of cholesterol biosynthesis by 3-hydroxy-3-methylglularyl (HMG)-CoA reductase inhibitors or statins improves clinical outcomes in patients with atherosclerosis ( 1,2). HMG-CoA reductase inhibitors exert antiatherosclerotic effects, beyond the normalization of hypercholesterolemia, by directly acting on endothelial cells, macrophages and VSMC (30).
IIMG-CoA reductase inhibitors reduce cardiovascular events even in patients without hypercholesterolemia, and inhibit the synthesis of isoprenoid intermediates such as farnesvlpyrophosphate (FIT) and geranylgeranylpyrophosphate (GGI'P). Both FPP and GGl'l' are important lipid attachments for the post-transcriptional modification of several proteins, including small G proteins Ras and RI10 GTP-binding proteins. . The involvement of small G proteins in iNOS induction is complex as has been described in different cell types (8) (9) (10) . The present study examines the effects of Τ IMGCo A reductase inhibitors on immunostimulantsinduccd NO production in VSMC. Since the intracellular concentration of tetrahydrobiopterin (BH-4), an essential colactor of NO synthase(s), could be rate limiting for NO synthesis, we also investigated the effects of IIMG-CoA reductase inhibitors on biopterin biosynthesis in cytokine-stimulated VSMC.
Materials and Methods
Mannheim). Several clones were selected for analysis of NF-kB activation.
Nuclear run-on assay
Isolation of nuclei and in vitro transcription pro ceeded as described (15) . Linearized plasmids containing target cDNAs dissolved in 0.4 M NaOH were immobilized onto Hybond-N+ nylon membranes (Amersham Pharmacia) and hybridized with the labeled RNA as described. Blots were exposed to an imaging plate (Fuji Photo Film Co.) and signal intensity was quantified using a FU.IIX bioimaging analyzer (BAS2000II).
Cell culture
Rat VSMC were isolated by elastase and collagenase digestion of thoracic aorlae front male Wistarrats as described (11).
Nitrite assay
Nitrite accumulation, an indicator of NO synthesis, was measured in the cell culture medium of confluent VSMC (12) . Nitrite was quantified colorimetrically after adding Griess reagent to samples. Nitrite concentrations were calculated by comparison with the absorbance of standard solutions of sodium nitrite prepared in cell culture medium.
iNOS and GTI'CH mRNA analysis Standard Northern blotting was used to investigate the mRNA expression lor iNOS and GTPCII as previously described (13) .
Assay of biopterin
Biopterin (Bl ft and more oxidized species) were measured essentially as described (14) . Cells were treated with 0.2 M perchloric acid and oxidized by exposure for lh at room temperature in the dark to 0.2 M perchloric acid containing 0.2% t and 0.4% Kl. Ascorbate (2%) was added to remove residual free I2, and the mixture was then centri fuged for 10 min at 10,000 χ g. Biopterin in the supernatant were quantified by reversed-phase high-performance liquid chromatography on a Ci« column with fluorescence detection using authentic biopterin as the standard.
NF-idi activation
To study NF-kH activation, the cells were stably transfected with a eis-reporter plasmid containing a luci ferase reporter gene linked to five repeats of NF-kB binding sites (pNFicB-I.uc: Stratagene) ( 1 3). For this, the pNFKB-Lue plasmid was transfected together with a pSV2neo helper plasmid (Clontech) into rat VSMC using the FuGFN 6 trans lection reagent (Boehringer
Statistical.
Analysis Data arc presented as means ± SEM. Multiple comparisons were evaluated by ANOVA followed by Fisher's protected least significant difference test. The results from two experiments were compared using Student's unpaired I test. A value of P<.05 was considered statistically significant.
Results

Interleukin-lß
(IL-1, 10 ng/'mL) activates rat VSMC to synthesize and release nitrite. IL-l-induced nitrite release was markedly potentiated by intcrferon-γ (IFN, 100 unit/mL). In contrast, VSMC treated On the other hand, the hydrophilic drug pravastatin had no effect on IL-1-induced nitrite production even at 100 niM (data not shown).
We examined whether or not statins affect activation of the NF-κΒ system. NF-kB activation was detected by measuring NF-KB-dependent transcription in rat VSMC stably translected with a luciferase reporter construct. Cells were incubated with various concentrations of cerivastatin or fluvastatin, then stimulated with IL-l/IFN for 3 h. In the absence of the statins, NF-KB was activated by TL-1/IFN. This activation was modestly affected by the statins (Fig. 2) . Cerivastatin slightly increased the NF-KB activity at concentrations of 1.25 -12.5 μΜ, while fluvastatin significantly decreased with increasing concentrations.
To identify the product of the HMCTCoA reductase reaction necessary for the effect of cerivastatin or fluvastatin, mevalonate, FPP, or ( iGPP was added to VSMC" stimulated with IL-l/IFN in the presence of the statins. Mevalonate is a cholesterol precursor, and FPP and GGPP are respectively involved in farnesylation and geranylgeranylation of proteins. Mevalonate (0.1 ntM) completely reversed the statin-induced increase in nitrite production (Fig. 3) .
Similarly, Figure GGPP (10 μΜ) completely reversed the statin-induced increase in nitrite production, whereas FPP (10 μΜ) did not block this effect of the statins (Fig. 3) . Mevalonate, FPP. and GGPP alone did not affect the basal or IL-1/IFN-induccd nitrite production (data not shown ).
We investigated whether or not the upregulation of transcriptional activity by statins impacts gene expression by evaluating iNOS mRNA levels by Northern blotting. Treatment with IL-1TFN provided a stimulus for iNOS mRNA expression (Fig. 4A) and this was clearly increased by the statins. We also examined whether or not statins increase the transcription rate of the iNOS gene using nuclear run-on analysis.
The transcription rate of the iNOS gene was substantially increased when assessed 8 h after exposure to ILl/IFN, and enhanced by the statins (Fig. 4B) . Both statins did not affect the ^ability of iNOS mRNA (data not shown). Unstimulated VSMC contained negligible amounts of biopterin. However, incubating the cells with IL-1/1FN substantially increased the cellular biopterin content. We examined the effects of statins on the IL-1/IF'N-induced increase in the cellular biopterin content. Both cervastatin and lluvastatin dose-dependentlv enhanced the IE-1/IFN-induced increase in cellular biopterin levels (Fig. 5A) . To evaluate how the statins induced Bi li, we investigated the effect of statins on the IL-1/IFN-induced increase in GTPCH mRNA. Whereas GTPCH mRNA levels are very low in untreated VSMC, IL-l/IFN increased the amount of the transcript after 24 h (Fig. 5B) . The statins substantially upregulated the IE-lTFN-induccd GTPCH mRNA levels.
Discussion
The present findings demonstrated that HMG-CoA reductase inhibitors enhanced the induction of NO synthesis bv cytokines in. VSMC. I IMG-Co A reduc- gene driven by IL-l/IFN. which »3. no: associated with NF-KB activity. We therefore concluded that HMG-CoA reductase inhibitors enhanced -.nimunostimulant-induced NO production by :ncrei;:n; :NOS gene expression at the transcriptional le . el an NF-KB-independent pathway Another important finding of this stud;. :s :r.a: HMG-CoA reductase inhibitors increase the cel ular content of BH4, the essential cofactor for NO formation. Cytokines induce the de novo synthesis of BHin VSMC, which is essential for the induction of NO synthesis (12) Activation of NO formation by cytokines in VSMC requires transcriptional induction of the genes that encode not only iNOS but also GTPCH, the first and rate-limiting enzyme in de novo BH4 synthesis (16) . Unstimulated VSMC express low levels of GTPCH mRNA. IL-l/IFN induced the expression of GTPCH mRNA in VSMC, and this was enhanced in the presence of HMG-CoA reductase inhibitors.
Parallel with the changes in GTPCH mRNA levels, cellular BH-t concentrations were increased to detectable levels by IL-l/IFN, and were further increased by HMG-CoA reductase inhibitors.
The stimulatory effect of HMG-CoA reductase inhibitors on iNOS parallels their ability to inhibit HMG-CoA reductase, since the effect of cerivastatin was greater than that of fluvastatin when evaluated with EC50. The hydrophilic drug pravastatin has no effect. Thus, the lipophilic properties of the compounds govern their effects at the cellular level. The present study found that mevalonate prevented the stimulatory effect of HMG-CoA reductase inhibitors on IL-l/IFN-induced NO production. Furthermore, we found that GGPP reversed the effect of the HMGCoA reductase inhibitors. Thus, the effcct of HMGCoA reductase inhibitors on NO production is due at least partly through blocking the biosynthesis of mevalonate, which prevents isoprenoid biosynthesis.
In summary, our data demonstrated that HMG-CoA reductase inhibitors enhance immunostimulantsinduced NO production by increasing iNOS gene expression at the transcriptional level via an NF-KBindependent pathway. In addition to augmenting iNOS expression, HMG-CoA reductase inhibitors potentiate GTPCH gene expression and BH4 synthesis, thereby prevents a relative shortage of BH4 which may shift in the balance between NOS-catalyzed generation of protective NO and deleterious reactive oxygen species.
